GG: n

S : MEDNET – http://www.medicinenet.com/levamisole-oral/article.htm (last access: 31 July 2015); NCBI – http://www.ncbi.nlm.nih.gov/pubmed/22455354 (last access: 31 July 2015).

N: 1. An anthelmintic drug C11H12N2S administered in the form of its hydrochloride that also possesses immunomodulatory properties and is used especially in the treatment of colon cancer.
2. Levamisole is used in cancer treatment because it interferes with the growth of cancer cells and slows their growth and spread in the body. This drug is used in the treatment of colon cancer although it may also be used for purposes other than those listed in this medication guide.
3. Some side effects have been reported with the use of levamisole including: allergic reactions (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); decreased bone marrow function or blood problems (fever or chills; or signs of infection); nervous system problems (confusion or loss of consciousness, extreme fatigue, memory loss, muscle weakness, numbness or tingling; seizure, speech disturbances) and others.
4. This drug is commercialized under the name Ergamisol.
5. An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects.

S: 1. MW – http://www.merriam-webster.com/dictionary/levamisole (last access: 31 July 2015). 2, 3 & . Drugs.com – https://www.drugs.com/international/levamisole.html (last access: 31 July 2015). 5. TERMIUM PLUS (last access: 31 July 2015).

SYN:
S:

CR: helminth, helminthiasis, parasitosis.